Alten SA (0O1S)
London Exchange · UK · prices in EUR · close of 20 Oct 2026
Key indicators
| Last close | EUR 84.05 |
|---|---|
| 52-week range | 49.24 – 85.70 |
| Return, 1 month / 3 months | +19.6% / +47.7% |
| Return, 1 year / 3 years | +22.6% / −20.3% |
| Trend | Uptrend |
| RSI (14) | 65 |
| Volatility (1 year) | 44.0% |
| Worst drawdown (1 year) | -38.2% |
| Average daily value traded | 0.87M EUR |
| Dividend yield | 1.8% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Alten is a French engineering and technology consulting group based in Boulogne-Billancourt, near Paris. It provides consulting and engineering services to clients in industries such as automotive, aerospace, defence, telecoms, energy and life sciences. Its teams work on design, development and information technology projects, helping customers plan and deliver complex technical programmes. The company operates through a network of offices in France and other countries, serving large industrial groups and other organisations that need specialist engineering expertise.
On this site Alten SA appears as a stock on the London Exchange (UK), code 0O1S, with prices in euros (EUR). Our dividend records, which start in 2019, show payments in 7 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Alten SA (0O1S) trades on the London Exchange in UK. It last closed at EUR 84.05 on 20 October 2026.
Its price-based Market X-Ray is 64 out of 100 (a fair price profile), ranking 1,039 of 3,787 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 22.6% and over the last three months it rose 47.7%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on London Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 91 · Strong | Trading above its long-term averages and near its highs. | |
| Above 200-day average | 29.8% | ||
| From 52-week high | -1.2% | ||
| Momentum | 79 · Strong | Rising faster than most stocks on this exchange. | |
| 3-month return | 47.7% | ||
| 6-month return | 47.4% | ||
| 12-month return, skipping the last month | 2.5% | ||
| Stability (higher is calmer) | 34 · Weak | Volatile, with deep drawdowns. | |
| Volatility, 1 year (lower is calmer) | 44.0% | ||
| Worst drawdown, 1 year (smaller is calmer) | -38.2% | ||
| Liquidity | 51 · Fair | Moderate trading activity. | |
| Average daily value traded | 0.87M EUR | ||
| Zero-volume days | 0.0% | ||
| Income | 49 · Weak | Dividend is small or irregular. | |
| Dividend yield | 1.8% | ||
| Years with dividends | 5 |
Strengths
- Trend: Trading above its long-term averages and near its highs.
- Momentum: Rising faster than most stocks on this exchange.
Weak spots
- Stability (higher is calmer): Volatile, with deep drawdowns.
- Income: Dividend is small or irregular.
Returns
| 1 week | +0.9% |
|---|---|
| 1 month | +19.6% |
| 3 months | +47.7% |
| 6 months | +47.4% |
| 1 year | +22.6% |
| 3 years | −20.3% |
| 5 years | −31.3% |
Signals
| 50-day / 200-day average | 75.61 / 64.73 |
|---|---|
| Golden / death cross (60 days) | Golden, 42 days ago |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 3.36 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 22 Jun 2026 | EUR 1.5000 |
| 16 Jun 2025 | EUR 1.5000 |
| 24 Jun 2024 | EUR 1.5000 |
| 4 Jul 2023 | EUR 1.5000 |
| 27 Jun 2022 | EUR 1.3000 |
| 2 Jun 2021 | EUR 1.0000 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on London Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.